Abstract
Transcription factor 4 (TCF4) is a proneural basic helix-loop-helix transcription factor that plays a critical role in brain development and is associated with a variety of psychiatric disorders including autism spectrum disorder (ASD), major depressive disorder, and schizophrenia. Autosomal dominant mutations in TCF4 result in a profound neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS). Germline TCF4 loss-of-function (LOF) studies using human and mouse models have identified dysregulation in neural cell proliferation, genesis, and specification which lead to disruption in neuronal, astroglial and oligodendroglial lineages. In this study, we focused on the role of TCF4 in the genesis of the astrocyte lineage, specifically in the context of modeling PTHS. We show that germline heterozygous mutations in Tcf4 had no effect on the expression of astrocyte marker genes in primary astrocyte cultures and whole brain lysates. Immunohistochemical (IHC) analysis of pan- and subclass-specific astrocyte markers showed Tcf4 mutation had no effect on the proportions of astrocytes in the dorsal cortex and corpus callosum. Lastly, we tracked ventrally-derived astrocytes using an Nkx2.1 reporter mouse and observed that germline Tcf4 LOF did not result in misallocation of ventrally-derived astrocytes into the dorsal cortex, a phenotype previously observed when both Tcf4 alleles were conditionally deleted in the Nkx2.1 lineage. These data indicate that germline heterozygous TCF4 LOF, which models PTHS, does not appear to affect the astrocyte lineage at the cell population level.